SureTrader
Home > Boards > US OTC > Biotechs > Delcath Systems Inc. (DCTH)

"phase 3 study on a life extending Cancer

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
andrius Member Profile
Member Level 
Followed By 113
Posts 15,553
Boards Moderated 3
Alias Born 04/14/04
160x600 placeholder
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 4/20/2018 11:29:18 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 4/9/2018 5:23:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 5:23:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2018 8:32:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/26/2018 4:40:15 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/16/2018 9:54:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/13/2018 8:53:28 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 3/13/2018 8:51:14 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 2/26/2018 5:14:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/28/2017 4:33:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2017 9:01:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2017 8:41:07 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2017 5:33:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/3/2017 8:48:10 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/2/2017 5:21:25 PM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/11/2017 6:11:55 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/11/2017 6:03:34 AM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 10/4/2017 12:55:02 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 9/21/2017 5:05:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2017 5:02:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2017 1:21:26 PM
Data on Delcath’s CHEMOSAT System Presented at CIRSE Annual Meeting GlobeNewswire Inc. - 9/19/2017 8:30:00 AM
Delcath Announces Accelerated Listing on OTCQB GlobeNewswire Inc. - 9/14/2017 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2017 4:32:32 PM
Delcath Announces Relisting on OTCQB GlobeNewswire Inc. - 9/13/2017 6:30:00 AM
andrius Member Level  Wednesday, 01/03/18 04:11:16 PM
Re: tickerpicker post# 29177
Post # of 41263 
"phase 3 study on a life extending Cancer treatment with high likelihood of success"

Yet they could not find a partner or funding? Well funding that wasn't toxic? Pharmas shell out billions for promising drugs but not for slam dunk cancer drug that would have cost them 10-20M?

Uplist is not going to happen way things are. For one they don't even meet MC requirements. With OS likely in 300M+ range within few months how are they going meet min price requirements? There is no way this is going to $1.5 BILLION market cap on pink sheets. They'd have to do another massive reverse split. Price would crash again and they would have trouble meeting MC requirement.

Also they are burning through cash fast. They'll need to raise again. Which will end with this stock where its been last couple months as all old shareholder value will get wiped out again. Just got to hope note holders sell out quick enough and give this some time to bounce without a huge selling ceiling overhead.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist